Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Echo IQFRA:PL4 -7.89%14 3-Year EPS without NRI Growth Rate is -15.90% as of Jun. 2026. GuruFocus rates FRA:PL4 with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 502 Healthcare Providers & Services companies, Echo IQ ranks worse than 80.68% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was -15.90% per year.
During the past 5 years, the average EPS without NRI Growth Rate was -18.10% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 21.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Echo IQ was 70.40% per year. The lowest was -66.50% per year. And the median was -6.30% per year.
Echo IQ (FRA:PL4) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Echo IQ 3-Year EPS without NRI Growth Rate Related Terms
FRA:PL4 vs VEEV, BTSG, TEM: 3-Year EPS without NRI Growth Rate Comparison
For the Health Information Services subindustry, Echo IQ's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Echo IQ 3-Year EPS without NRI Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Echo IQ's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Echo IQ's 3-Year EPS without NRI Growth Rate falls into.
Echo IQ 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of -15.90% mean?
Echo IQ (FRA:PL4) has a 3-Year EPS without NRI Growth Rate of -15.90% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Echo IQ and its competitors. According to the industry distribution chart, Echo IQ ranks #405 out of 502 companies in the Healthcare Providers & Services industry, placing it in the top 80.7%.
Is Echo IQ's 3-Year EPS without NRI Growth Rate too high?
Echo IQ's current 3-Year EPS without NRI Growth Rate is -15.90%. Based on the distribution chart, Echo IQ ranks #405 out of 502 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Echo IQ has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Echo IQ's 3-Year EPS without NRI Growth Rate compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Echo IQ ranks #405 out of 502 companies for 3-Year EPS without NRI Growth Rate. This places Echo IQ in the lower half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 10.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EPS without NRI Growth Rate among Healthcare Providers & Services companies is 10.90, based on 502 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Echo IQ and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EPS without NRI Growth Rate is 10.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Echo IQ's current 3-Year EPS without NRI Growth Rate is -15.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Echo IQ stock overvalued right now?
Echo IQ (FRA:PL4) has a current 3-Year EPS without NRI Growth Rate of -15.90%. The current 3-Year EPS without NRI Growth Rate is -15.90%. Echo IQ's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Echo IQ (FRA:PL4), the current 3-Year EPS without NRI Growth Rate is -15.90% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Echo IQ Ltd is an Australian medical technology company focused on improving decision-making in cardiology. Its proprietary EchoSolv platform leverages AI-driven analysis of echocardiographic data to help clinicians detect Aortic Stenosis (AS) and other conditions with greater accuracy and efficiency. The company is focused on expanding its strategic partnerships, progressing regulatory pathways, and completing successful deployments of its technology in the USA healthcare market to establish its position in AI-enabled cardiovascular care.
14GF Score
Get the complete analysis for FRA:PL4
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PL4 has been successfully added to your 
